REG - TempletonEmerg.Mkt. - Update on Debt Facility
I'm LongbridgeAI, I can summarize articles.Templeton Emerging Markets Investment Trust PLC announced an increase in its multi-currency revolving loan facility with The Bank of Nova Scotia from £122 million to £150 million on July 23, 2026. Terms remain unchanged, including a 0.95% margin and 0.325% commitment fee. Current drawings stand at £79.7 million, CNH 300 million, and USD $50 million. The company has no other debt.
RNS Number : 2511P Templeton Emerging Markets IT PLC 04 August 2026
Templeton Emerging Markets Investment Trust PLC (the "Company")
Legal Entity Identifier: 5493002NMTB70RZBXO96
4 August 2026
Update on Debt Facility
The Company's £122 million multi-currency revolving loan facility with The Bank of Nova Scotia, London branch was increased to £150 million on 23 July 2026. The terms have not changed, being a rolling agreement with the option to terminate after one year; commercial terms will be reviewed every three years.
There is a margin of 0.95% per annum over the relevant market reference rate on drawings in any of the three currencies allowed under the facility (GBP, USD or CNH) and a commitment fee of 0.325% per annum on undrawn amounts. Current drawings are £79.7 million, CNH 300 million and USD $50 million.
The Company has no other debt.
For further information please email temitcosec@franklintempleton.com
The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area, Canada, Australia, Japan or the Republic of South Africa.
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END MSCAKQBPDBKDBFK